{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04721",
    "Peptide Name": "VM-3G (VM P3G analog, Leu-rich, synthetic AMPs, XXA, UCLL1c; BBMm)",
    "Source": "amino acid substitution, insects, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLGIIGKLLSGLL",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Anti-MRSA",
      "Hemolytic",
      "Antibiofilm"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": -2.4,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "62%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toVCP-VT1 or VML: 38%, G: 23%, I: 15%.Activity: Active against Gram+ S. aureus NCTC 6538 or MRSA ATCC 12493 (MIC 1-2 uM), E. faecalis NCTC 12697 (MIC 4 uM), Gram- E. coli ATCC 8739 (MIC 64 uM), K.pneumoniae ATCC 43816 (MIC 512 uM), P.aeruginosa ATCC 9027 (MIC >128 uM), and yeast C. albicans ATCC 10231 (MIC >512 uM). Also inhibited biofilms:bacteria:S. aureus (MBIC 2 uM; MBEC 32 uM); biofilms:bacteria:E. faecalis (MBIC 8 uM).MOA:bacteria:S. aureus: it permeabilized bacterial membranes (2xMIC, 50%).Structure:  random coil in 10 mM NH4Ac and helical in 50% TFE/NH4Ac.In vitro toxicity: horse RBC: HC50 9.7 uM, hemolytic.Animal model:wax moth: survival study: it protected the worms from death in a dose-dependent manner.Resistance development:no:bacteria:S. aureus: no resistance development after 16 cycles of passages.",
    "Author": "Zhang J, Sun R, Chen Z, Zhou C, Ma C, Zhou M, Chen X, Chen T, Shaw C, Wang L.2022",
    "Reference": "Biology (Basel). 2022 Aug 25;11(9):1263. doi: 10.3390/biology11091263.PubMed",
    "Title": "Evaluation of the Antimicrobial Properties of a Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues as a Possible Route to Defeat Drug-Resistant Microbes."
  },
  "3D Structure": []
}